ArticleHaematologica2023

Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?

Mahesh Swaminathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.